Related Experiment Video
Updated: May 25, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Functional mapping of the A2 domain from human factor VIII
Jean-Luc Plantier1, Didier Saboulard, Jean-Luc Pellequer
1Laboratoire d’Hémobiologie EA4174-IFR62 Faculté de Médecine RTH Laennec, Université de Lyon, Lyon, France. plantierj@lfb.fr
Researchers identified key amino acid residues in the Coagulation factor VIII (FVIII) A2 domain essential for its cofactor function. Mutating these critical residues significantly impacts FVIII activity, revealing structural importance for maintaining blood clotting.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Coagulation factor VIII (FVIII) is a vital glycoprotein for blood clotting.
- The FVIII A2 domain is a critical structural component influencing its cofactor function.
Purpose of the Study:
- To identify specific residues within the FVIII A2 domain crucial for maintaining its cofactor activity.
- To map the structural and functional importance of amino acids in the FVIII A2 domain.
Main Methods:
- Generated 206 alanine substitution mutants within the FVIII A2 domain.
- Expressed mutants in COS-1 cells and measured antigen levels and procoagulant activities.
- Classified mutants based on activity loss and analyzed mutation sensitivity patterns.
Main Results:
- Identified 63 mutants with severely affected activity (<15%) and 98 with non-detrimental alterations (>50%).
- Found clusters of mutation-sensitive residues (e.g., Arg418-Phe436) buried within the A2 domain, suggesting structural roles.
- Identified mutation-resistant residues forming external loops, less critical for factor X activation.
Conclusions:
- Detailed map of FVIII A2 domain (residues 371-649) created, highlighting functionally critical residues.
- Buried residues are essential for A2 domain structure and FVIII function, while external loops are less critical.
- Identified residues crucial for FVIII function and those amenable to mutation without compromising coagulant activity.
More Related Videos
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
11:17Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...